Search the Newsreel

Edesa Biotech Inc reports results for the quarter ended June 30 - Earnings Summary

Edesa Biotech Inc has reported its earnings for the quarter that ended on June 30. The article provides a summary of these results. To access the full details, readers are directed to the complete article available through TradingView, which offers unlimited access to Reuters …

Archimedes Tech SPAC Partners II Reports Q2 2026 10-Q with Significant PIPE-Related Losses

Archimedes Tech SPAC Partners II reported a significant net loss of $135,048,119 for the first half of 2026, primarily due to a $100,000,000 PIPE subscription expense and a $37,942,000 adjustment in the fair value of a PIPE subscription derivative liability. This contrasts sharply with …

Diodes (DIOD) director Evan Yu receives 2,250 restricted stock units vesting from 2027

Diodes Incorporated director Evan Yu was awarded 2,250 restricted stock units (RSUs) on August 12, 2026, at no cash cost, under a Rule 16b-3 Plan. These RSUs will vest in four equal installments starting May 26, 2027. Following this grant, Yu's direct ownership in …

A Look at Autodesk Inc (ADSK) After 3.4% Gain -- GF Value $346.7

Autodesk Inc (ADSK) shares recently rose 3.4% to $257.96. According to GuruFocus, the stock is "Modestly Undervalued" with a GF Value of $346.74, indicating a 25.6% margin of safety. The company boasts a strong GF Score of 86/100 due to high growth and profitability, …

Transcript : AXISCADES Technologies Limited, Q1 2027 Earnings Call, Aug 13, 2026

$Destiny Tech100 (DXYZ.US)$ Decide for yourself whether to sell[Shy](SPCX once rose to 73 before its IPO) NFA

An investor shared a post on the Moomoo Community regarding Destiny Tech100 (DXYZ.US), suggesting others decide whether to sell their shares. The post referenced SPCX's past performance, noting it rose to 73 before its IPO. This is presented as "NFA" (Not Financial Advice).

Biodesix Inc (BDSX) major holder Jack W. Schuler buys 15,000 shares

Jack W. Schuler, a major holder and emeritus director of Biodesix Inc. (BDSX), indirectly purchased 15,000 shares of common stock on August 12, 2026. The shares were bought at a weighted average price of $24.4661 per share through the Jack W. Schuler Living Trust, …

Biodesix Insider Bought Shares Worth $366,992, According to a Recent SEC Filing

An insider at Biodesix (BDSX) recently purchased shares valued at $366,992, as disclosed in a recent SEC filing. This transaction was published on August 13, 2026, at 05:40 pm EDT, according to MT Newswires. Biodesix specializes in diagnostic solutions, particularly for lung cancer testing …

Edesa Biotech Q3 Results: EPS misses estimate, losses widen 140% YoY

Autodesk Inc. stock underperforms Thursday when compared to competitors despite daily gains

Autodesk Inc. (ADSK) shares increased by 3.39% on Thursday, closing at $257.96, breaking a two-day losing streak. Despite this gain, the stock underperformed compared to the broader market, as the S&P 500 Index and Dow Jones Industrial Average also saw gains. The article highlights …

Edesa Biotech (EDSA) loss widens to $11.9M as R&D surges and cash tightens

Archimedes Tech SPAC III (ARCI) shows $280M in trust and Q2 2026 net income

Archimedes Tech SPAC Partners III Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Archimedes Tech SPAC (ATII) details $1.2B Forge Nano deal and $135M loss

Archimedes Tech SPAC Partners II Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Edesa Reports $5.4 Million Q3 Loss as EB06 Phase 2 Site Activation Begins

Edesa Biotech (EDSA) reported a net loss of $5.4 million for Q3 2026, an increase from $1.7 million in the prior year, primarily due to rising operating expenses from its Phase 2 EB06 vitiligo study. The company is beginning site activation for this study …

Autodesk (ADSK) shareholder files to sell 2,400 vested shares on NASDAQ

A shareholder of Autodesk, Inc. (ADSK) has filed a Form 144 notice to sell 2,400 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services. The proposed sale is valued at approximately $600,000.00 and consists of shares that vested from restricted …

Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results

Edesa Biotech (Nasdaq: EDSA) reported its fiscal third-quarter 2026 results, showing a net loss of $5.4 million due to increased operating expenses. The company announced it has completed preparations for its Phase 2 EB06 vitiligo trial and begun activating initial investigational sites, with patient …

Plano&Plano (PLPL3): Expansão da receita compensada por margens mais fracas

Desun Real Estate Issues Profit Warning Amid Costly Business Transformation

AXISCADES Q1 Results: Net loss widens to ₹1,475.96 lakh, defence revenue up

Mercedes Benz Group (XTRA:MBG) Stock May Be A Bargain As Fleet Charging Deal Expands

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Mercedes-Benz Group stock has fallen 25.4% year to date, yet the valuation checks point to a company that looks roughly in line with …

Diodes Incorporated Announces Proposed Private Placement of $325 Million of Convertible Senior Notes

PLANO, Texas, August 13, 2026--(BUSINESS WIRE)--Diodes Incorporated ("Diodes") (Nasdaq: DIOD), today announced it intends to offer, subject to market conditions and other factors, $325 million aggregate principal amount of Convertible Senior Notes due 2031 (the "notes") in a private placement (the "offering") only to …

Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages

Biodesix, Inc. (NASDAQ:BDSX) has received a "Moderate Buy" consensus rating from five brokerages, with an average 12-month price target of $31.33. This comes as the company exceeded quarterly expectations, reporting revenues of $26.86 million and a lower-than-expected adjusted loss per share. Insider activity also …

MELK3 - Melnick - Resultados, Dividendos, Cotação e Indicadores

Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference

Biodesix reaffirmed its full-year revenue guidance of $108 million to $114 million, representing approximately 25% year-over-year growth at the midpoint, and expects to achieve positive adjusted EBITDA on a run-rate basis soon. The company highlighted growth in its Nodify CDT test, driven by commercial …

Melnick (MELK3): Lucro acima das estimativas apesar da desaceleração da receita

Mercedes-Benz Group (XTRA:MBG) Following Its Fleet Charging Deal And The Undervalued Narrative

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Why the new fleet charging partnership matters for Mercedes-Benz Group stock Mercedes-Benz Group (XTRA:MBG) is back in focus after ChargePoint extended its partnership with Mercedes-Benz AG to …

Insider Buying: Biodesix (NASDAQ:BDSX) Director Purchases 13,900 Shares

Biodesix (NASDAQ:BDSX) Director Jack Schuler recently purchased 13,900 shares of the company's stock for over $337,000, increasing his direct stake by 2.71%. The company reported better-than-expected quarterly revenue and EPS, although it remains unprofitable. Analysts maintain a "Moderate Buy" rating for Biodesix with an …

Is Diodes Inc (DIOD) Overvalued After 3.8% Rally? GF Value Says

Diodes Inc (DIOD) recently saw its shares rally by 3.8% to $107.04, but GuruFocus's GF Value suggests the stock is significantly overvalued by 58.7%, with an estimated intrinsic value of $67.44. The company has a strong financial strength rating of 9/10 but a weak …

Cadence Design Systems, Inc. (CDNS) Stock Forecasts

Argus has lowered its target price for Cadence Design Systems, Inc. (CDNS) to $367.00. The report, published on August 12, 2026, identifies Cadence Design Systems as a provider of electronic design automation software, intellectual property, and system design and analysis products. The current price …

Biodesix director Jack Schuler buys $665,940 in company stock

Biodesix Inc. (NASDAQ:BDSX) Director Jack W. Schuler recently acquired 27,600 shares of company stock for approximately $665,940 through two transactions on August 10 and 11, 2026. These purchases occurred as the stock trades near its 52-week high after a 257% year-to-date surge, despite InvestingPro …

Diodes (DIOD) Q2 2026 Earnings Call Transcript

Biodesix (BDSX) major holder Jack W. Schuler adds shares via trusts

Jack W. Schuler, a major shareholder and emeritus director of Biodesix Inc. (BDSX), has increased his holdings through open-market purchases made via the Jack W. Schuler Living Trust. Over two days, August 10 and August 11, 2026, Schuler acquired a total of 27,600 shares …

Marble Design Factory Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Descartes Group’s Earnings Rise Validates Bullish View On Supply Chain Software